• 1
    Matricardi PM, Bjorksten B, Bonini S, Bousquet J, Djukanovic R, Dreborg S et al. Microbial products in allergy prevention and therapy. Allergy 2003;58: 461471.
  • 2
    Williams HC. Is the prevalence of atopic dermatitis increasing? Clin Exp Dermatol 1992;17: 385391.
  • 3
    Williams H, Robertson C, Stewart A, Ait-Khaled N, Anabwani G, Anderson R et al. Worldwide variations in the prevalence of symptoms of atopic eczema in the International Study of Asthma and Allergies in Childhood. J Allergy Clin Immunol 1999;103: 125138.
  • 4
    Gehring U, Bolte G, Borte M, Bischof W, Fahlbusch B, Wichmann HE et al. Exposure to endotoxin decreases the risk of atopic eczema in infancy: a cohort study. J Allergy Clin Immunol 2001;108: 847854.
  • 5
    Harris JM, Cullinan P, Williams HC, Mills P, Moffat S, White C et al. Environmental associations with eczema in early life. Br J Dermatol 2001;144: 795802.
  • 6
    Kilpi T, Kero J, Jokinen J, Syrjanen R, Takala AK, Hovi T et al. Common respiratory infections early in life may reduce the risk of atopic dermatitis. Clin Infect Dis 2002;34: 620626.
  • 7
    Renz H, Herz U. The bidirectional capacity of bacterial antigens to modulate allergy and asthma. Eur Respir J 2002;19: 158171.
  • 8
    Rautava S, Kalliomaki M, Isolauri E. Probiotics during pregnancy and breast-feeding might confer immunomodulatory protection against atopic disease in the infant. J Allergy Clin Immunol 2002;109: 119121.
  • 9
    Kirjavainen PV, Apostolou E, Salminen SJ, Isolauri E. New aspects of probiotics – a novel approach in the management of food allergy. Allergy 1999;54: 909915.
  • 10
    Christensen HR, Frokiaer H, Pestka JJ. Lactobacilli differentially modulate expression of cytokines and maturation surface markers in murine dendritic cells. J Immunol 2002;168: 171178.
  • 11
    Kalliomaki M, Salminen S, Arvilommi H, Kero P, Koskinen P, Isolauri E. Probiotics in primary prevention of atopic disease: a randomised placebo-controlled trial. Lancet 2001;357: 10761079.
  • 12
    Kalliomaki M, Salminen S, Poussa T, Arvilommi H, Isolauri E. Probiotics and prevention of atopic disease: 4-year follow-up of a randomised placebo-controlled trial. Lancet 2003;361: 18691871.
  • 13
    Isolauri E, Arvola T, Sutas Y, Moilanen E, Salminen S. Probiotics in the management of atopic eczema. Clin Exp Allergy 2000;30: 16041610.
  • 14
    Viljanen M, Savilahti E, Haahtela T, Juntunen-Backman K, Korpela R, Poussa T et al. Probiotics in the treatment of atopic eczema/dermatitis syndrome in infants: a double-blind placebo-controlled trial. Allergy 2005;60: 494500.
  • 15
    Weston S, Halbert AR, Richmond P, Prescott SL. Effects of probiotics on atopic dermatitis: a randomised controlled trial. Arch Dis Child 2005; doi:10.1136/adc.2004.060673.
  • 16
    Cross ML, Stevenson LM, Gill HS. Anti-allergy properties of fermented foods: an important immunoregulatory mechanism of lactic acid bacteria? Int Immunopharmacol 2001;1: 891901.
  • 17
    Rosenfeldt V, Benfeldt E, Nielsen SD, Michaelsen KF, Jeppesen DL, Valerius NH et al. Effect of probiotic Lactobacillus strains in children with atopic dermatitis. J Allergy Clin Immunol 2003;111: 389395.
  • 18
    Williams HC. On the definition and epidemiology of atopic dermatitis. Dermatol Clin 1995;13: 649657.
  • 19
    Kunz B, Oranje AP, Labreze L, Stalder JF, Ring J, Taieb A. Clinical validation and guidelines for the SCORAD index: consensus report of the European Task Force on Atopic Dermatitis. Dermatology 1997;195: 1019.
  • 20
    de Champs C, Maroncle N, Balestrino D, Rich C, Forestier C. Persistence of colonization of intestinal mucosa by a probiotic strain, Lactobacillus casei subsp. rhamnosus Lcr35, after oral consumption. J Clin Microbiol 2003;41: 12701273.
  • 21
    Kailasapathy K, Chin J. Survival and therapeutic potential of probiotic organisms with reference to Lactobacillus acidophilus and Bifidobacterium spp. Immunol Cell Biol 2000;78: 8088.
  • 22
    Szilagyi A. Review article: Lactose – a potential prebiotic. Aliment Pharmacol Ther 2002;16: 15911602.
  • 23
    Szilagyi A. Redefining lactose as a conditional prebiotic. Can J Gastroenterol 2004;18: 163167.
  • 24
    De Preter V, Geboes K, Verbrugghe K, De Vuyst L, Vanhoutte T, Huys G et al. The in vivo use of the stable isotope-labelled biomarkers lactose-[15N]ureide and [2H4]tyrosine to assess the effects of pro- and prebiotics on the intestinal flora of healthy human volunteers. Br J Nutr 2004;92: 439446.
  • 25
    Schley PD, Field CJ. The immune-enhancing effects of dietary fibres and prebiotics. Br J Nutr 2002;87(Suppl. 2):S221230.
  • 26
    Boehm G, Jelinek J, Knol J, M'Rabet L, Stahl B, Vos P et al. Prebiotics and immune responses. J Pediatr Gastroenterol Nutr 2004;39(Suppl. 3):S772773.
  • 27
    Salek MS, Finlay AY, Luscombe DK, Allen BR, Berth-Jones J, Camp RD et al. Cyclosporin greatly improves the quality of life of adults with severe atopic dermatitis. A randomized, double-blind, placebo-controlled trial. Br J Dermatol 1993;129: 422430.
  • 28
    van Joost T, Heule F, Korstanje M, van der Broek MJ, Stenveld HJ, van Vloten WA. Cyclosporin in atopic dermatitis: a multicentre placebo-controlled study. Br J Dermatol 1994;130: 634640.
  • 29
    Gutgesell C, Heise S, Seubert S, Seubert A, Domhof S, Brunner E et al. Double-blind placebo-controlled house dust mite control measures in adult patients with atopic dermatitis. Br J Dermatol 2001;145: 7074.
  • 30
    Roller M, Rechkemmer G, Watzl B. Prebiotic inulin enriched with oligofructose in combination with the probiotics Lactobacillus rhamnosus and Bifidobacterium lactis modulates intestinal immune functions in rats. J Nutr 2004;134: 153156.